search
Back to results

Assessment of the Effectivity of Total-face Mask for Noninvasive Ventilation During Acute Respiratory Failure

Primary Purpose

Respiratory Insufficiency

Status
Terminated
Phase
Phase 4
Locations
Spain
Study Type
Interventional
Intervention
Total Face Mask
Sponsored by
Corporacion Parc Tauli
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Respiratory Insufficiency focused on measuring Noninvasive Mechanical Ventilation, Acute Respiratory Failure, Intubation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Acute Hypoxemia:PaO2/FiO2 lower than 200 mmHg Respiratory rate greater than 30 breaths/min Exclusion Criteria: cardiogenic lung edema COPD exacerbation Low level of consciousness (GCS < 13) Hemodynamic instability Facial damage Do-not-intubate orders Lack of informed consent

Sites / Locations

  • Hospital de Sabadell

Outcomes

Primary Outcome Measures

Intubation rate

Secondary Outcome Measures

Hospital survival

Full Information

First Posted
October 24, 2005
Last Updated
September 14, 2015
Sponsor
Corporacion Parc Tauli
search

1. Study Identification

Unique Protocol Identification Number
NCT00243828
Brief Title
Assessment of the Effectivity of Total-face Mask for Noninvasive Ventilation During Acute Respiratory Failure
Official Title
Assessment of the Effectivity of Total-face Mask for Noninvasive Ventilation During Acute Respiratory Failure: a Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2007
Overall Recruitment Status
Terminated
Why Stopped
Very low rate of recruitment anticipated futility of pursuing the study
Study Start Date
November 2005 (undefined)
Primary Completion Date
September 2007 (Actual)
Study Completion Date
December 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Corporacion Parc Tauli

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Total-face mask may improve the efficacy of NIV compared to conventional face mask in patients with acute respiratory failure due to enhanced tolerance and the allowance of higher airway pressure without massive leaks.MAIN OBJECTIVE: To assess, in acute respiratory failure patients, whether the total-face mask reduce the intubation rate. METHODS: 300 patients admitted in the ICU for acute respiratory failure needing continuous noninvasive mechanical ventilation. The type of mask (total-face vs. conventional face mask) will be randomized. Defined failure criteria and weaning technique will be used.
Detailed Description
HYPOTESIS: Total-face mask may improve the efficacy of NIV compared to conventional face mask in patients with acute respiratory failure due to enhanced tolerance and the allowance of higher airway pressure without massive leaks.OBJECTIVES: To assess, in acute respiratory failure patients, whether the total-face mask reduce the intubation rate. Additionally, whether it may improve mask tolerance, skin pressure damage, number of patients receiving higher pressures, or even a reduction in mortality. METHODS: 300 patients admitted in the ICU for acute respiratory failure needing continuous noninvasive mechanical ventilation. The type of mask (total-face vs. conventional face mask) will be randomized. PEEp will be titrated to the best oxygenation and IPAP up to reduce dyspnea and respiratory frequency, with the limits at clinical tolerance and massive leaks. Defined failure criteria and weaning technique will be used. Data to record include clinical parameters and mortality risk score (SAPS II), and physiologic response to NIV (either subjective and objective), technique failures and outcome. EXPECTED RESULTS: The study has been powered to detect a 30% relative improvement in intubation rate from a 35% baseline incidence of intubation in the conventional group.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Insufficiency
Keywords
Noninvasive Mechanical Ventilation, Acute Respiratory Failure, Intubation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
300 (false)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
Total Face Mask
Primary Outcome Measure Information:
Title
Intubation rate
Secondary Outcome Measure Information:
Title
Hospital survival

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Acute Hypoxemia:PaO2/FiO2 lower than 200 mmHg Respiratory rate greater than 30 breaths/min Exclusion Criteria: cardiogenic lung edema COPD exacerbation Low level of consciousness (GCS < 13) Hemodynamic instability Facial damage Do-not-intubate orders Lack of informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rafael Fernandez, MD, PhD
Organizational Affiliation
Corporacion Parc Tauli
Official's Role
Study Director
Facility Information:
Facility Name
Hospital de Sabadell
City
Sabadell
State/Province
Barcelona
ZIP/Postal Code
08208
Country
Spain

12. IPD Sharing Statement

Learn more about this trial

Assessment of the Effectivity of Total-face Mask for Noninvasive Ventilation During Acute Respiratory Failure

We'll reach out to this number within 24 hrs